XERACALM A.D
Replenishing balm
XERACALM AD Replenishing balm has been specially formulated to meet the needs of very dry skin with an atopic tendency. Thanks to its patented biotechnological active ingredient I-Modulia, optimized by the Dextrabiome, it directly targets the virulence factors of Staphylococcus aureus at the heart of the skin microbiome.
This skin care product immediately soothes itching, reduces the frequency of intense dryness flare-ups and offers prolonged efficacy for at least 6 months1.
It nourishes the skin for 48 hours2 and penetrates quickly, leaving no greasy film.
Two alternative textures are available, offering the same triple efficacy:
IMMEDIATE SOOTHING - ANTI-DRYNESS - ANTI-RELAPSE: Cream and Milky Gel
- Terms of use
-
1Clinical research under dermatological and pediatric control, 2 applications per day for 6 months, 65 subjects, no relapse for 98% of patients, limits the risk of recurrence of intense dryness flare-ups.
2Instrumental test, 2 applications / day for 7 days, 20 subjects
-
For whom?From 1 year oldChildrenAdults
-
Price400mL26,90 €200mL20,90 €
-
Texture-Balm texture- Penetrates quickly without leaving a greasy film
Patient relations
-
Application tips
1- Cleanse skin with Xeracalm A.D lipid replenishing oil
2 - Nourish with Xeracalm A.D Replenishing balm for 48 hours of nourishment and a triple action: immediate soothing, anti-itching, anti-relapse.
3 - Immediately soothe intense itching with Xeracalm A.D Soothing Concentrate, to take anywhere.
-
In combination with the following treatments
Proven tolerance in association with atopic dermatitis and oncology treatments.
Ingredients
Active ingredients:

I-modulia® is the first multi-competent biotechnological active ingredient derived from Avène Thermal Spring Water. It directly targets the factors involved in atopic eczema.

The most effective nutrient complex identified in over 20,000 models1. Provides the lipids essential to the proper functioning of the skin barrier and reinforces it.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
SCORAD IN ONE MONTH1
FLARE-UP FOR 6 MONTHS2
ITCHING FROM 1 WEEK3
DRYNESS FROM 1 WEEK3
Legal notes
1Clinical scoring (SCORAD) under dermatological and pediatric control, 65 subjects, twice-daily application for 6 months, body and face.
2Clinical scoring, 2 applications per day for 6 months, 65 subjects, no relapse for 88% of patients, limits the risk of repeated severe dryness flare-ups.
3Clinical scoring (SCORAD) under dermatological and pediatric control, 65 subjects, twice-daily application for 6 months, body and face.
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.